Exelixis Inc at Oppenheimer Healthcare Conference (Virtual) Transcript
Hello, everyone, and welcome to Oppenheimer's 33rd Annual Healthcare Conference. I'm Jay Olson, one of the biotechnology analysts at Oppenheimer. And I want to thank you all for joining us here today.
It's my pleasure to welcome Exelixis to our conference. And it's an honor to introduce Michael Morrissey, President and CEO. Thank you, Michael, so much for joining us here today.
Jay, it's great to be here. Sorry, we're not doing this live. I guess there's weather on both coasts today. So maybe this is probably the most expedient way to be able to chat. So yes, it's great to be here.
Before we begin, let me just mention that I'll be making forward-looking statements today. So please see our SEC filings for a description of the risks that we face in our business.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
